Understanding Meningioma Hyperostosis in Neurosurgical Practice

Meningiomas are the most common primary central nervous system tumors in adults, originating from arachnoid cap cells. Among their varied presentation features, meningioma hyperostosis remains an important clinical finding. Hyperostosis refers to localized bony thickening or osteosclerosis of the skull adjacent to tumor attachment. Neuroradiologists frequently detect these bony alterations during preoperative magnetic resonance imaging and computed tomography scans. However, the precise biological mechanisms driving adjacent bone growth have remained incompletely understood. Historically, clinicians debated whether hyperostosis reflects reactive bone formation induced by osteoinductive growth factors or direct tumor cell invasion into surrounding cranial structures.

Understanding histological correlates of meningioma hyperostosis is vital for refining surgical strategy and post-operative monitoring. Bony expansion complicates resections, requiring extensive calvarial drilling, skull base reconstruction, and careful protection of critical neurovascular structures. Furthermore, residual hyperostotic bone can harbour microscopic tumor nests, serving as a potential source for late recurrence. To clarify these pathophysiological relationships, a recent neurosurgical study analyzed a large retrospective patient cohort undergoing surgical resection for cranial meningiomas, evaluating how bone modifications relate to tumor grade, histological subtype, anatomical site, and proliferative capacity.

Cohort Characteristics and Retrospective Study Design

The retrospective investigation evaluated 245 patients presenting with 263 cranial meningiomas resected over a three-year period. To maintain diagnostic consistency, researchers included only meningiomas situated immediately adjacent to the inner skull table. The histological spectrum encompassed 202 WHO grade 1 benign meningiomas, 53 WHO grade 2 atypical lesions, and 8 WHO grade 3 anaplastic tumors. Demographic characteristics, comprehensive preoperative neuroimaging, and detailed histopathological records were systematically evaluated using rigorous statistical methods.

Radiological assessments recorded hyperostosis presence and evaluated contiguous structural involvement, including bone invasion. Pathologists reviewed surgical specimens to assign official WHO tumor grades and characterize specific histological subtypes. Additionally, immunohistochemical staining for Ki-67 nuclear antigen quantified cellular proliferative activity across tumor samples. Univariate and multivariate statistical analyses were performed to identify correlations between hyperostosis, histological phenotypes, anatomical locations, and biological markers. By examining this well-defined surgical cohort, investigators sought to clarify long-standing questions regarding cranial bone modifications in meningioma management. Understanding these associations helps multidisciplinary neuro-oncology teams refine diagnostic algorithms and personalize surgical approaches for patients presenting with complex skull lesions.

Histological Subtypes and WHO Grade Correlations

A primary study objective was determining whether meningioma hyperostosis correlates with specific histological subtypes or WHO grades. Hyperostosis was identified in 99 of 263 meningiomas, representing an overall prevalence of 38 percent. The most common histological variants among hyperostotic tumors included meningothelial, transitional, fibrous, atypical, and anaplastic subtypes. However, statistical evaluations revealed no significant relationship between hyperostosis and specific histological subtypes. Consequently, classic histological classification alone cannot predict whether an individual tumor will induce bone hyperplasia in adjacent skull structures.

Similarly, statistical analysis demonstrated no significant association between WHO tumor grade and hyperostosis. Benign WHO grade 1 tumors exhibited hyperostotic bone changes at rates comparable to higher-grade WHO grade 2 and grade 3 lesions. This finding indicates that bone proliferation is not a marker of histological malignancy or accelerated cellular turnover. Clinicians cannot assume that marked calvarial hyperostosis indicates an aggressive tumor phenotype. Instead, bone changes reflect localized osteoinductive pathways that operate independently from standard WHO histological grading parameters. Therefore, radiographically evident hyperostosis should be evaluated independently from assumed pathological aggressiveness during initial clinical workups.

Inverse Link Between Proliferative Index and Hyperostosis

Immunohistochemical analysis yielded notable insights regarding cellular proliferation, evaluated via the Ki-67 labeling index. As expected, mean Ki-67 indices correlated significantly with advancing WHO grade, confirming higher proliferative activity in atypical and anaplastic meningiomas. Surprisingly, when analyzing bone modifications, researchers discovered a statistically significant inverse correlation. Specifically, meningiomas without hyperostosis exhibited significantly higher mean Ki-67 proliferation indices compared to tumors displaying prominent hyperostosis. Multivariate regression confirmed lower Ki-67 expression as an independent predictor of hyperostosis.

This negative correlation suggests an interesting biological dichotomy between tumor growth velocity and osteoinductive activity. Slowly proliferating meningiomas persist in proximity to the skull over longer durations, facilitating sustained paracrine interactions with adjacent bone tissue. Indolent tumor cells gradually release osteoinductive cytokines and growth factors that stimulate bone remodeling. Conversely, rapidly growing meningiomas with elevated Ki-67 indices expand quickly, causing early neurological symptoms and prompt surgical removal before prolonged bone remodeling can occur. Thus, hyperostosis frequently signifies a chronologically mature, slower-growing tumor process. Recognizing this inverse relationship offers reassuring prognostic context when managing extensive hyperostotic skull base lesions.

Anatomic Distribution and Bone Invasion Dynamics

Anatomical tumor location proved to be a critical factor in hyperostosis development. Skull base meningiomas exhibited hyperostosis significantly more often than convexity meningiomas. Multivariate analysis confirmed skull base location as a strong, independent positive predictor of hyperostosis. The intricate anatomy of the skull base, featuring complex sutures, rich vascularity, and tight dural attachments, fosters enhanced cross-talk between neoplastic cells and adjacent osseous structures compared to the smooth cranial vault.

Furthermore, multivariate testing established a strong positive correlation between microscopic bone invasion and macroscopic hyperostosis. While bone invasion did not correlate with Ki-67 proliferation rates, its association with hyperostosis indicates that tumor cell infiltration into bony trabeculae directly triggers hyperplastic osteoblast activity. Neoplastic cells infiltrating cortical bone stimulate reactive bone formation while simultaneously altering trabecular architecture. Clinically, hyperostotic skull changes should generally be managed as harboring microscopic tumor cells rather than representing purely reactive bone expansion. Complete surgical removal or thorough drilling remains crucial for durable tumor control. Neuro-oncologists must integrate these anatomical and histopathological insights to formulate effective individual treatment strategies.

Frequently Asked Questions

Is meningioma hyperostosis an indicator of tumor malignancy?

No, meningioma hyperostosis does not indicate malignancy. Research shows no statistically significant correlation between hyperostosis and WHO tumor grade or aggressive histological subtypes. Furthermore, hyperostotic tumors frequently demonstrate lower Ki-67 proliferation indices compared to non-hyperostotic tumors, suggesting an indolent, slower-growing tumor biology.

Why is hyperostosis more common in skull base meningiomas?

Skull base meningiomas develop in close proximity to complex bony structures, rich vascular networks, and dural attachments. These anatomical characteristics promote sustained paracrine signaling and microscopic cellular infiltration between tumor tissue and adjacent osseous structures, leading to higher rates of hyperostosis compared to convexity lesions.

How does hyperostosis impact the surgical management of meningiomas?

Hyperostosis strongly correlates with microscopic tumor invasion into adjacent bone. Therefore, surgeons strive to resect or drill hyperostotic bone completely to reduce recurrence risks. When complete bony resection is unsafe due to critical neurovascular structures, close post-operative imaging surveillance or adjuvant therapies are recommended.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. Refer to the latest local and national guidelines for clinical practice.

References

1. Cook WH et al. Hyperostosis in meningioma: a retrospective exploration of histological correlates. Br J Neurosurg. 2026 Feb. doi: 10.1080/02688697.2024.2400134. PMID: 39258390.


2. Di Cristofori A, Del Bene M, Locatelli M, et al. Meningioma and bone hyperostosis: expression of bone stimulating factors and review of the literature. World Neurosurg. 2018;118:e836-e844.